Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts
There are limited data on alcohol dose and types and risk of Crohn’s Disease (CD) and Ulcerative Colitis (UC). Researchers sought to comprehensively examine the association between alcohol consumption and risk of CD and UC. A prospective cohort study was conducted of 237,835 participants from the Nurses’ Health Study, Nurses’ Health Study II, and Health Professional Follow-Up Study. Alcohol consumption was obtained through questionnaires submitted every four years; additional covariates were obtained at two or four-year intervals. Cases were confirmed independently by two physicians through medical record review. Across 5,170,474 person-years of follow-up, 370 cases of CD and 486 cases of UC were documented. Increased consumption of alcohol intake was not associated with CD or UC. Compared to non-users, the multi-variable adjusted HRs for 15.0 + g/day of alcohol intake group were 0.84 (95% CI 0.56, 1.24) for CD and 1.08 (95% CI 0.77, 1.51) for UC. In analyses of alcohol subtypes, only moderate consumption of beer (>1-4 servings/week) was marginally associated with reduced risk of CD, while consumption of >4 servings/week of liquor was associated with an increased risk of UC. This prospective study did not identify a relationship between overall alcohol consumption and risk of CD or UC. The authors state that the suggestive associations between alcohol types and risk of CD and UC deserve additional investigation. Source: Casey K, Lopes EW, Niccum B, Burke K, Ananthakrishnan AN, Lochhead P, Richter JM, Chan AT, Khalili H. Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts. Aliment Pharmacol Ther. 2022 Jan;55(2):225-233. .
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.